Keywords: اینترفرون بتا; Multiple sclerosis; Interferon Beta; Magnetic resonance imaging; Spinal cord; Treatment response;
مقالات ISI اینترفرون بتا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترفرون بتا; Anti-drug antibodies; Neutralizing antibodies; Bioassay; Luciferase; Interferon beta; Multiple sclerosis;
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon beta; Glatiramer acetate; Suboptimal response; Disability; Prediction;
Keywords: اینترفرون بتا; Interferon beta; Multiple sclerosis; Sex; Therapy response
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon beta; Glatiramer acetate; Compliance; Satisfaction; Quality of lifeEsclerosis múltiple; Interferón beta; Acetato de glatirámero; Cumplimiento; Satisfacción; Calidad de vida
Keywords: اینترفرون بتا; Asthma; Biologics; Therapeutics; AQLQs; Asthma quality of life questionnaires; EPR3; Expert Panel Report 3; FEV1; Forced expiratory volume in 1 second; FENO; Fractional exhaled nitric oxide; GM-CSF; Granulocyte-macrophage colony-stimulating factor; ICS;
Keywords: اینترفرون بتا; Glycoengineering; Interferon beta; Comparative modeling; Molecular dynamics; In silico design
Keywords: اینترفرون بتا; Multiple sclerosis; Thrombotic microangiopathy; Interferon Beta; Disease modifying treatment; Thrombotic thrombocytopenic purpura; Malignant hypertension;
Keywords: اینترفرون بتا; Multiple sclerosis; Mortality; Immodulatory treatment; Interferon beta
Keywords: اینترفرون بتا; Measles virus; Virus-host interaction; Interferon beta; Interstrain differences; Proteomics;
Keywords: اینترفرون بتا; Acute disseminated encephalomyelitis; Multiphasic disseminated encephalomyelitis; Interferon beta; Multiple sclerosis; Neuromyelitis optica;
Keywords: اینترفرون بتا; TLR; Toll-like receptor; PRISM; PRotein Interactions by Structural Matching; IAP; inhibitors of apoptosis; ECM; extracellular matrix; ROS; reactive oxygen species; IBD; inflammatory bowel disease; NSAIDs; non-steroidal anti-inflammatory drugs; TGF-β; tra
Keywords: اینترفرون بتا; Newcastle disease virus; Chicken IFN-γ; Pathogenesis; Immunopathogenesis; Cytokine storm; Reverse genetics; NDV; Newcastle disease virus; ND; Newcastle disease; IFN-γ; interferon gamma; IFN-α; interferon alpha; IFN-β; interferon beta; IL-6; interleuki
Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability
Keywords: اینترفرون بتا; RRMS; Interferon beta; Neutralizing antibody; Rebif®; ReciGen®;
Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients
Keywords: اینترفرون بتا; Interferon beta; Multiple sclerosis; Neutralizing antibodies; T cell; Antigenic epitope; Anti-drug antibodies;
Polyglutamine binding protein 1 (PQBP1) inhibits innate immune responses to cytosolic DNA
Keywords: اینترفرون بتا; PQBP1; polyglutamine binding protein 1; cGAS; cyclic GMP-AMP synthase; IFI16; interferon- γ-inducible protein 16; IFN; interferon; STING; Stimulator of Interferon Genes; TBK; tank-binding kinase-1; DNA sensing; PQBP1; cGAS; IFI16; pattern recognition rec
In vitro models for deciphering the mechanisms underlying the sexual transmission of viruses at the mucosal level
Keywords: اینترفرون بتا; BSA; Bovin Serum Albumin; CCL5; Chemokine Ligand 5; CCR7; Chemokine Receptor Type 7; CD; Cluster of Differentiation; CMV; Cytomegalovirus; DC-SIGN; Dendritic Cell-Specific ICAM-Grabbing Non-integrin; DNA; Deoxyribonucleic Acid; EDTA; Ethylenediaminetetraa
TNFRSF1A and MEFV mutations in childhood onset multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; Childhood; Familial Mediterranean fever; FMF; Tumor necrosis factor receptor 1-associated periodic syndrome; TRAPS; EDSS; expanded disability status scale; FMF; familial Mediterranean fever; IFNβ; interferon beta; MEFV; Mediterranean
Neuroprotective effect of monophosphoryl lipid A, a detoxified lipid A derivative, in photothrombotic model of unilateral selective hippocampal ischemia in rat
Keywords: اینترفرون بتا; MPL; monophosphoryl lipid A; LPS; lipopolysaccharide; TLR4; toll like receptor 4; i.c.v; intracerebroventricular; TTC; triphenyltetrazolium chloride; RAWM; radial arm water maze test; PA; passive avoidance test; NF-κB; nuclear factor kappa beta; TNF-α;
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients
Keywords: اینترفرون بتا; Multiple Sclerosis; B cells; IRF-1; CXCL10 axis; Hsa-miR-424; Transcriptome analysis; CXCL10; C-X-C motif chemokine 10; EBV; Epstein-Barr Virus; IRF1; interferon response factor 1; MS; Multiple sclerosis; RT-PCR; real-time PCR; RR-MS; relapsing remitting
Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents
Keywords: اینترفرون بتا; MAPK; RAF inhibitors; Anti-cancer agents; Abl; Abelson murine leukemia viral oncogene; ATP; Adenine triphosphate; Bcl-2; B-cell lymphoma; CNS; Central nervous system; COX-2; Cyclo-oxygenase enzyme-2; CR; Conserved region; CRD; Cysteine-rich domain; DFG; A
Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM
Keywords: اینترفرون بتا; clinical; delayed-release dimethyl fumarate; interferon beta; neuroradiological; relapsing-remitting multiple sclerosis; safety;
Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay
Keywords: اینترفرون بتا; Dengue virus; Severe dengue; Immune response; Type I interferon; Interferon alpha; Interferon beta;
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review
Keywords: اینترفرون بتا; Multiple Sclerosis; Interferon beta; Nephrotic syndrome;
Targeted mutations in Val101 and Arg27 interferon beta protein increase its transcriptional and translational activities
Keywords: اینترفرون بتا; ARE elements; Codon 101; Interferon beta; Real-time PCR;
Short communicationTLR3 signaling is downregulated by a MAVS isoform in epithelial cells
Keywords: اینترفرون بتا; TLR3; MAVS; Isoform; Interferon beta; Regulation; Epithelial cells; miniMAVS; HCT116;
Desarrollo de panuveítis por tuberculosis en paciente con esclerosis múltiple tratado con interferón beta
Keywords: اینترفرون بتا; Tuberculosis ocular; Panuveítis; Esclerosis múltiple; Corticoides; Interferón betaOcular tuberculosis; Panuveitis; Multiple sclerosis; Corticoids; Interferon beta
ASF1a enhances antiviral immune response by associating with CBP to mediate acetylation of H3K56 at the Ifnb promoter
Keywords: اینترفرون بتا; ASF1a; anti-silencing function 1a; CBP; CREB binding protein; TLRs; Toll-like receptors; RLRs; RIG-I-like receptors; IRF3; interferon regulatory factor 3; VSV; vesicular stomatitis virus; SEV; simian enterovirus; IFN-β; interferon beta; QPCR; quantitativ
Alteration of canonical and non-canonical WNT-signaling by crystalline silica in human lung epithelial cells
Keywords: اینترفرون بتا; ACTA2; Actin, alpha, smooth muscle; ANGPTL4; Angiopoietin-like 4; ANOVA; Analysis of variance; AXIN; Axis inhibition protein; BMP; Bone morphogenic protein; BMPR1B; BMP receptor 1B; CACNA2D3; Calcium channel, voltage-dependent, alpha 2/delta subunit 3; CC
The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6
Keywords: اینترفرون بتا; Interferon alpha; Interferon beta; STAT6; Sp1; BCL6; Anti-proliferation activities;
Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple Sclerosis
Keywords: اینترفرون بتا; Interferon beta; IFNAR; Soluble receptor; EAE; Multiple Sclerosis;
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients
Keywords: اینترفرون بتا; MS; multiple sclerosis; IFN-β; interferon beta; NAbs; neutralizing antibodies; MxA; myxovirus resistance A; PCR; polymerase chain reaction; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; EDSS; Expanded Disability Status Scale; EDMUS; European Database
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
Keywords: اینترفرون بتا; ALI; acute lung injury; APCs; antigen-presenting cells; ARE; antioxidant responsive element; Bach1; Broad complex-Tramtrack-Bric-a-brac (BNB) and Cap'n'collar (CNC) homolog 1; BAL; bronchoalveolar lavage; BR; bilirubin-IXα; BV; biliverdin-IXα; BVR;
IFN-β differentially regulates the function of T cell subsets in MS and EAE
Keywords: اینترفرون بتا; APC; antigen-presenting cell; BBB; blood-brain barrier; CCR; C-C chemokine receptor; CNS; central nervous system; CSF; cerebrospinal fluid; CXCR; C-X-C chemokine receptor; EAE; experimental autoimmune encephalomyelitis; FoxA; forkhead box protein A; FOXP3
Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis
Keywords: اینترفرون بتا; ARR; annualized relapse rate; CI; confidence interval; EDSS; Expanded Disability Status Scores; Gd+; gadolinium-enhancing; IFN beta; interferon beta; IFN beta-1a; interferon beta-1a; IM; intramuscular; MedDRA; Medical Dictionary for Regulatory Activities;
Protocolo terapéutico de las formas progresivas primarias y secundarias de la esclerosis múltiple
Keywords: اینترفرون بتا; Esclerosis múltiple; Primaria progresiva; Secundaria progresiva; Tratamiento; Interferón beta; Multiple sclerosis; Primary progressive; Secondary progressive; Treatment; Beta interferon;
Evaluation of the impact of neutralizing antibodies on IFNβ response
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon beta; Neutralizing antibodies; MxA; Biological activity
Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity
Keywords: اینترفرون بتا; A(H1N1)pdm09; pandemic influenza H1N1, 2009; IL; interleukin; IFN-β; interferon beta; MCP-1; monocyte chemoattractant protein 1; TNF-α; tumor necrosis factor-alpha; TGF-β; transforming growth factor-β; Influenza virus; A(H1N1)pdm09; Cytokines; Chemoki
Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques
Keywords: اینترفرون بتا; Inflammation; Atherosclerosis; Macrophage; FPN; ferroportin1; GM1; GM1 ganglioside; HH; hemoglobin:haptoglobin complex; Hep; hepcidin; INF-β; interferon beta; KO; knockout; LPS; lipopolysaccharide; Ox LDL; oxidized LDL; PCR; polymerase chain reaction; TI
Cumplimiento terapéutico con terapias modificadoras de la enfermedad de primera lÃnea en pacientes con esclerosis múltiple. Estudio COMPLIANCE
Keywords: اینترفرون بتا; Esclerosis múltiple; Interferón beta; Acetato de glatirámero; Cumplimiento; Satisfacción; Calidad de vida; Multiple sclerosis; Interferon beta; Glatiramer acetate; Compliance; Satisfaction; Quality of life;
Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs
Keywords: اینترفرون بتا; Multiple sclerosis;; Interferon beta;; Immunogenicity;; Transient and sustainedneutralizing antibody;; Antibody dissociation rate;; Biacoreâ¢;
Levels of mRNA for dopaminergic receptor D5 in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; Interferon beta; Lymphocytes; Dopaminergic receptors; β2-Adrenoceptors; Tyrosine hydroxylase;
Arsenic programmes cellular genomic-immunity through miR-2909 RNomics
Keywords: اینترفرون بتا; miRNA; MicroRNA; PBMCs; Peripheral blood mononuclear cells; CYLD; Cylindromatosis; KLF4; Kruppel-like factor4; NFκB; Nuclear factor kappa B; FCS; Foetal Calf Serum; As; Arsenic; IFNβ; Interferon beta; APOBEC3G; Apolipoprotein B mRNA-editing, enzyme-cata
Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells
Keywords: اینترفرون بتا; Interferon beta; Insect cell expression; Soluble protein; Natively folded; Endotoxin-free; Biologically active;
Immunoglobulin G1 and immunoglobulin G4 antibodies in multiple sclerosis patients treated with IFNβ interact with the endogenous cytokine and activate complement
Keywords: اینترفرون بتا; Interferon beta;; Relapsing-remitting multiple sclerosis;; Immunogenicity;; Anti-drug antibody;; Neutralising antibody;; Complement;
Spinal Toll-like receptor signaling and nociceptive processing: Regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFNβ
Keywords: اینترفرون بتا; Interferon beta; Intrathecal injection; Tactile allodynia; Toll-like receptors; Tumor necrosis factor;
Characterization and Quantitation of Aggregates and Particles in Interferon-β Products: Potential Links Between Product Quality Attributes and Immunogenicity
Keywords: اینترفرون بتا; proteins; protein aggregation; subvisible particles; nanoparticles; microparticles; interferon beta; immunogenicity; biopharmaceuticals characterization; analytical ultracentrifugation;
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis
Keywords: اینترفرون بتا; Multiple sclerosis; Pregnancy; Interferon beta; Glatiramer acetate
Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced Myocarditis
Keywords: اینترفرون بتا; interferon beta; myocarditis; protease-activated receptor 2; Toll-like receptor 3AP, activating peptide; CAR, coxsackievirus-adenovirus receptor; CCL, chemokine ligand; CD, cluster of differentiation; CVB3, coxsackievirus B3; DAF, decay-accelerating recep
Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma
Keywords: اینترفرون بتا; Malignant glioma; Apoptosis; Gene delivery; PAMAM-R; Interferon beta